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In recent years, many studies have examined the pulp-dentin complex regeneration with DPSCs. While it is important to perform
research on cells, scaffolds, and growth factors, it is also critical to develop animal models for preclinical trials. The development
of a reproducible animal model of transplantation is essential for obtaining precise and accurate data in vivo.The efficacy of pulp
regeneration should be assessed qualitatively and quantitatively using animal models. This review article sought to introduce in
vivo experiments that have evaluated the potential of dental pulp stem cells for pulp-dentin complex regeneration. According to a
review of various researches about DPSCs, the majority of studies have used subcutaneous mouse and dog teeth for animal models.
There is no way to know which animal model will reproduce the clinical environment. If an animal model is developed which is
easier to use and is useful in more situations than the currently popular models, it will be a substantial aid to studies examining
pulp-dentin complex regeneration.
1. Introduction
Since Kakehashi et al. reported that bacteria caused pulpitis
in their mouse experiment in 1965, endodontic treatment
has developed with the goal of the complete removal of
bacteria from the root canal [1]. It was believed that, once
exposed to bacteria, the dental pulp would fall into a state
of irreversible pulpitis that could never be restored to the
normal state and that the progression of inflammation would
result in necrosis. Therefore, the dental pulp tissues that are
damaged due to bacterial invasion or dental trauma should
be removed. The conventional root canal treatment focuses
on three-dimensional mechanical preparation, disinfection,
and the tight sealing of the root canal space to completely
eliminate the dental pulp and bacteria in the root canal and
prevent reinfection. However, this treatment is only a mea-
sure aimed at repair rather than true healing/regeneration.
Thus, many studies have been conducted in the field of dental
endodontics with the aim of pulp regeneration.
Two approaches have been undertaken for dental pulp-
dentin complex regeneration. The first approach is the revas-
cularization procedure.Many case reports have found clinical
success following revascularization procedures, for example,
no symptoms and no periapical lesions [2–4]. However,
the histological observations from animal experiments have
revealed that the tissues formed in the root canal do not
reflect the regeneration of pulp-dentin but are rather formed
of periodontal tissues, such as cementum, periodontal liga-
ment, and bone [5, 6].The revascularization procedure has its
own clinical advantages in the treatment of immature teeth,
but it does not result in pulp-dentin complex regeneration in
the true sense.
The second approach for regenerating the dental pulp-
dentin complex is the transplantation of mesenchymal stem
cells into endodontically treated canals. In recent years,
various stem cells have been isolated from the oral cavity.
In 2000, Gronthos et al. isolated dental pulp stem cells
(DPSCs) from human 3rd molars for the first time, and these
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Table 1: Description of in vivo experiments with the application of DPSCs for pulp-dentin complex regeneration.
Author Animal Ectopic/orthotopic Source of stem cell
Shi et al., 2005 [17] IC mice Ectopic (subcutaneous) hDPSCs, SHED, hPDLSCs
Okamoto et al., 2009 [18] IC mice Ectopic (subcutaneous) hDPSCs
Alongi et al., 2010 [19] IC mice Ectopic (subcutaneous) hDPSCs
Huang et al., 2010 [20] IC mice Ectopic (subcutaneous) hDPSCs, SCAP
Wang et al., 2010 [21] IC mice Ectopic (subcutaneous) hDPSCs
Galler et al., 2011 [22] IC mice Ectopic (subcutaneous) hDPSCs, SHED
Lee et al., 2011 [23] IC mice Ectopic (subcutaneous) hDPSCs
Choung et al., 2013 [25] IC mice Ectopic (subcutaneous) hDPSCs
Yu et al., 2006 [26] Rats Ectopic (renal capsule) hDPSCs
Yu et al., 2007 [27] Rats Ectopic (renal capsule) hDPSCs, BMSSCs
Yu et al., 2008 [28] Rats Ectopic (renal capsule) hDPSCs
Iohara et al., 2004 [29] Dogs Orthotopic (canine) Porcine pulp cells
Iohara et al., 2009 [30] Dogs Orthotopic (canine) SP cells from canine pulp
Iohara et al., 2011 [31] Dogs Orthotopic (incisor) SP cells from canine pulp
Iohara et al., 2013 [32] Dogs Orthotopic (incisor) MDPSCs
Iohara et al., 2014 [33] Dogs Orthotopic (incisor) MDPSCs
Zhu et al., 2012 [34] Dogs Orthotopic (premolar) cDPSCs
Kodonas et al., 2012 [35] Mini pigs Orthotopic (incisor root, jaw bone) sDPSCs
IC, immunocompromised; hDPSCs, human dental pulp stem cells; SHED, stem cells from human exfoliated deciduous teeth; hPDLSCs, human periodontal
ligament stem cells; SCAP, stem cells from apical papilla; BMSSCs, bone marrow stromal stem cells; SP, side population; MDPSCs, DPSC subfraction based on
their migratory response to granulocyte-colony stimulating factor; cDPSCs, canine dental pulp stem cells; sDPSCs, swine dental pulp stem cells.
DPSCs were characterized as highly proliferative cells with
self-renewal multidifferentiation properties in vitro [7]. The
dental pulp is vascularized and characterized by innervated
loose connective tissue that contains heterogeneous cell
populations [8]. Due to the complexity of pulpal tissues,
no universally accepted protocols or cell types are currently
available to assess pulp regeneration. However, a consensus
exists regarding the importance of neural and vascular rein-
nervation for successful pulp regeneration [9]. DPSCs that
exhibit pluripotentmesenchymal stem cell characteristics can
be easily isolated from teeth [10].Therefore, the strong angio-
genic and neurogenic potentials of DPSCs have attracted
much attention in the study of pulp regeneration [11–13].
Tissue engineering approaches are based on three central
components: the living cells, scaffolds, and growth factors.
Various types of stem cells, scaffolds, and growth factors
have been researched and reported to function in pulp-
dentin complex regeneration. Before applying these candi-
date substances in clinical trials, their biocompatibilities and
treatment efficacies should be evaluated in vivo using animal
models. In pulp-dentin complex regeneration research, the
absence of animal models that adequately reflect pulp injury
and pulpitis for investigation of the use of DPSCs has resulted
in skipping preclinical testing. However, if the efficacy and
safety of a treatment have not been validated in animal
experiments, serious side effects can occur [14, 15]. Thus, the
development of a reproducible transplantation animal model
is essential for obtaining precise and accurate data in vivo
[16]. The efficacy of pulp regeneration should be assessed
qualitatively and quantitatively via the use of animal models.
This review article sought to introduce in vivo experi-
ments that have evaluated the possibilities of dental pulp stem
cells for pulp-dentin complex regeneration. This paper con-
centrates on the selection of in vivo and DPSC experiments
that were identified in the Medline database via PubMed.
2. In Vivo Engineering in Dental
Pulp Regeneration
2.1. Ectopic Transplantation versus Orthotopic Transplanta-
tion. The use of preclinical animal models is the most
informative approach to obtaining clinically relevant data
and verifying safety prior to human application. Animal
model designs are categorized into ectopic transplantation
and orthotopic transplantation. The word “ectopic” is from
theModern Latin from the Greek word ektopos,whichmeans
away from an original place or abnormal position. The word
“orthotopic” is from the Greek word orthos, which means
normal or usual position.
In pulp-dentin complex regeneration research, the
ectopic implantation of stem cell involves transplantation
of the cells into the outside of the tooth, for example,
into subcutaneous tissue or the renal capsule. Orthotopic
implantation involves the transplantation of the cells into
the root canal space. Table 1 summarized current in vivo
transplantation experiments with dental pulp stem cells.
2.2. In Vivo DPSCs Experiments: Ectopic Transplantation.
It is not easy to apply the various types of cells, growth
factors, and scaffolds that can be used controllably in in
vitro experiments using animals. In early stages, in vivo
experiments require large numbers of animals and easy access
to the points of application. Ectopic transplantation not only
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has the advantage of easy access but also has the advantages of
being rapid and reproducible, requiring minimal labor, being
relatively inexpensive, and producing easily quantifiable data
[36]. Ectopic implantation is typically chosen for investiga-
tions of the characteristics of newly discovered stem cells and
studies of the suitability of various scaffolds for dental tissue
engineering [37]. Small animals, such as mice or rats, are
preferred over large animals, such asmonkeys, dogs, and pigs,
due to costs, breeding management, and ethical issues.
Mice are the most commonly used species in ectopic
transplantation experiments. Mice are relatively inexpensive
and easy to handle and involve fewer ethical issues. Mouse
anatomy is well known to researchers, and the mouse
genome is 99% similar to the human genome [38]. Advances
in genetic engineering technology have allowed for the
generation of genetically modified mice. Severe combined
immune deficiency (SCID) mice are naturally born without
an immune system and can serve asmodels for allogeneic and
xenogeneic DPSC transplantations.
Almost all of the ectopic DPSCs transplantation experi-
ments have been performed in mouse subcutaneous tissue.
Subcutaneous transplantation is technically easy compared
with other sites and is less likely to result in the death of the
animal. Many researchers have studied the properties of the
mesenchymal stem cells derived from human dental tissue
using mouse subcutaneous tissues. Shi et al. obtained dental
pulp from impacted 3rd molars and digested tissues in colla-
genase/dispase to generate single-cell suspensions. Cultured
DPSCs were cotransplanted with hydroxyapatite/tricalcium
phosphate (HA/TCP) particles into the subcutaneous tissues
of immunocompromised mice for 8 weeks. Consequently,
donor-derived pulp-dentin-like tissues with distinct odon-
toblast layers lining the mineralized dentin matrix were
generated [17]. Researchers have demonstrated the pulp-
dentin complex regeneration capabilities of DPSCs in a
variety of environments with mice since the initial in vivo
and in vitro experiments identified the basic characteristics
of DPSCs. Okamoto et al. cultured DPSCs with simvastatin
for 7 days and transplanted DPSC-HA/TCP mixtures into
the dorsal subcutaneous tissues of 10-week-old immuno-
compromised mice for 8 weeks. The DPSCs pretreated by
high-concentration simvastatin formed significantly greater
amounts of mineralized tissue than those treated with low
concentrations and the controls [18]. Alongi et al. conducted
an experiment with mice to examine whether DPSCs could
be found in inflamed pulp as well as in normal pulp and
if the DPSCs from inflamed pulp would retain their tissue
regeneration potential following successful cultivation.These
authors reported that DPSCs obtained from inflamed pulp
also exhibited tissue regeneration capacities [19]. Huang
et al. established an artificial human root canal model in
which one end of the canal was opened to permit blood
supply and the other end was sealed with MTA [20]. In
research in which human root fragments were implanted into
immunocompromisedmice, DPSC cultures were observed to
result in pulp-like tissues with well-established vascularities.
This study provides the first evidence that pulp-like tissue can
be generated by DPSCs in the empty root canal space and
that odontoblast-like cells proliferate fromDPSCs to produce
dentin-like hard tissue on the dentinal walls. This research is
significant in that it used a human root model that created
an environment as similar as possible to that of orthotopic
implantations to overcome the limitations of ectopic implan-
tation. Additionally, research has been performed to assess
the effectiveness of scaffolds and to identify the factors that
influence the differentiation of DPSCs into odontoblasts [21–
23, 25].
In addition to subcutaneous tissues, renal capsules are
used in DPSC research. Yu et al. reported several in vivo stud-
ies using rat renal capsules [26–28]. The renal subcapsular
space is a good site for cell transplantation due to its high graft
uptake rate and abundant blood supply [39]. However, renal
capsules are not used frequently because they are difficult to
access compared with subcutaneous tissues.
2.3. In Vivo DPSCs Experiments: Orthotopic Transplantation.
In dental pulp regeneration research, orthotopic transplan-
tations involve implantation into the teeth, that is, the
original anatomical site. When teeth are used in research,
they can reflect the actual clinical environment better than
ectopic sites such as subcutaneous tissues and renal capsules.
However, it is not easy to implant a mixture of DPSCs and
scaffolds into animal teeth. This procedure requires particu-
larly advanced skills and techniques when using mice or rats,
which have tooth diameters of only 2–5mm.Therefore, larger
animals, such as dogs and pigs, are often preferred over mice
for this purpose [14].
Many dental experimental studies have been performed
in dogs. Dogs are considered an ideal animal model for
dental research due to the similarities in anatomy, growth
patterns, and pathophysiologies with humans [40]. Dogs are
diphyodonts with deciduous and permanent dentitions. The
composition of the permanent dentition is three incisors, one
canine, four premolars, and two molars in the maxilla and
three incisors, one canine, four premolars, and three molars
in themandible.Thebeagle is one of themost commonly used
dogs because this breed has a well-adjusted temperament and
is easy to handle due to its proper size [41].
Almost all research into the orthotopic transplantation of
DPSCs has been performed in dogs. Iohara et al. reported
various studies about DPSC implantations in dog teeth [29–
33]. In 2004, the efficacy of BMP2 on the differentiation
of DPSCs into odontoblasts was examined in a canine
amputated pulp model. A surgical exposure was made in
the canine, and the amputation was performed. The upper
incisor pulp was extracted and isolated, and the pulp cells
were enzymatically separated. The pellet of the dog pulp
cells was cultured and applied to the amputated root canal.
Consequently, the transplantation of the BMP2-treated pulp
cells into the amputated root canal stimulated reparative
dentin formation [29]. Subsequently, Iohara et al. studied
several factors that affect pulp regeneration using a surgically
amputated canine pulp model. These authors researched the
potential utility of a subfraction of a side population of
cells, that is, CD31−/CD146− and CD105+ immunophenotype
cells, from dog dental pulp for angiogenesis/vasculogenesis
and pulp regeneration in a surgically amputated canine
pulp model [30, 31]. These authors demonstrated successful
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pulp-dentin complex regeneration in canine teeth. The
same group also studied the effects of granulocyte colony-
stimulating factor and host age on pulp regeneration [32, 33].
In addition to Iohara, other researchers have conducted
research on pulp regeneration in dogs. Zhu et al. investigated
the pulp regeneration potential of DPSCs and platelet-rich
plasma (PRP) using the surgically amputated canine pulp
model established by the Iohara group [34]. Contrary to the
expectation that better results would be observed in a DPSC
and PRP group than in a blood clot group, histologic exam-
inations did not indicate any differences between the two
groups. These findings opposed those from previous in vitro
research that predicted that DPSCs plus PRP would play an
important role in pulp-dentin complex regeneration because
PRP contains many growth factors, and treatment with the
appropriate concentration of PRP has been shown to enhance
the proliferation andmineralization differentiation of DPSCs
[24], which indicates that the results obtained in the labora-
tory may not lead to results in preclinical animal studies.
Several studies have employed mini pigs. Kodonas et al.
demonstrated the regenerative capacity of swine DPSCs
seeded in organic and synthetic scaffolds and implanted into
the jaw bones of mini pigs [35]. These authors established a
root implant model. The root implants were manufactured
using the middle part of the roots of freshly extracted swine
incisors, and the root canalswere filledwith scaffolds contain-
ing DPSCs and then implanted into the fresh postextraction
sockets. This method is not truly orthotopic transplantation.
However, it can be used as a valuable animal model for
DPSC research in that it attempts to reproduce the clinical
environment as much as possible.
2.4. Other Orthotopic Transplantation Models. Although not
truly DPSC-based research, other efforts have been made to
create an animalmodel to identify the elements that influence
pulp regeneration [42, 43]. Torabinejad performed radio-
graphic and histologic examinations with ferret cuspid teeth
over 36–133 days after birth [43]. This author reported that
ferret cuspid teeth exhibit anatomical, physiologic, histologic,
and pathologic characteristics that are similar to those of
human teeth. The ferret has four single-root teeth that are
easily accessible for the performance of endodontic proce-
dures and easy to evaluate radiographically and histologically.
Torabinejad’s model holds some significance as an animal
model because ferrets are easier to handle and are cheaper
than dogs and present fewer ethical issues than dogs, which
are popular pets.
Other researchers have created orthotopic animal models
with small animals instead of large animals, such as dogs, pigs,
and ferrets. Simon et al. evaluate mice as an in vivomodel for
the study of pulpal healing in response to direct pulp capping
[42]. These authors proposed the possibilities of orthotopic
transplantation research with mouse teeth in preliminary
studies despite the difficult accessibility and the small sizes
of the teeth. Despite their many advantages as experiment
animals, small animals, such as rodents, have been considered
to be inappropriate for orthotopic transplantation animal
models due to their small teeth [14, 43]. However, it became
possible to apply DPSCs to the teeth of small animals and to
perform histological and radiological observations of those
teeth because of the use of microscopes, the developments in
experimental instruments, and the introduction of scaffold-
free approaches [42, 44]. Additional research on the devel-
opment of rodent animal models will aid the development of
new orthotopic models.
3. Conclusion
Recently, many studies have approached the pulp-dentin
complex regeneration with DPSCs. While it is important
to perform research on cells, scaffolds, and growth factors,
it is also critical to develop animal models for preclinical
trials. Although no human studies have yet been performed,
research has been conducted with various types of animals
and produced promising results.
According to a review of various studies of DPSCs, the
majority of studies have usedmouse subcutaneous tissues and
dog teeth for animal models. There is no way to know which
animal model better reproduces the clinical environment,
but the results of an orthotopic transplantation experiment
will be more reliable than those of ectopic transplantation
experiments. The problem is that orthotopic transplantation
research lags behind ectopic transplantation research in both
quantity and quality. Sufficient orthotopic transplantation
research should be conducted before clinical trials are initi-
ated. If an animal model is developed which is easier to use
and more versatile than the currently popular models (e.g.,
the canine pulp model), that model will be of substantial
benefit to research on pulp-dentin complex regeneration.
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